Alisha Kadam
Alisha Kadam
Research Assistant in Oncology, University of Alberta
Verified email at
Cited by
Cited by
Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines
M Najlah, A Kadam, KW Wan, W Ahmed, KMG Taylor, AMA Elhissi
International journal of pharmaceutics 506 (1-2), 102-109, 2016
Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature
AN Kadam, M Najlah, KW Wan, W Ahmed, SJ Crean, DA Phoenix, ...
Pharmaceutical development and technology 19 (8), 999-1004, 2014
Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature
CF Cho, L Yu, TK Nsiama, AN Kadam, A Raturi, S Shukla, GA Amadei, ...
Nanoscale 9 (33), 12096-12109, 2017
EGFL7 inhibits tumor angiogenesis via its Emilin-like domain
A Kadam
Paclitaxel loaded lipid nanoemulsions for the treatment of brain tumour
M Najlah, A Kadam, KW Wan, W Ahmed, A Elhissi
A novel EGFL7-derived peptide, E7C13, is a potent anti-tumor agent that inhibits angiogenesis in a beta 1 integrin-and thrombospondin-dependent manner
CF Cho, LA Fung, T Nsiama, L Yu, A Kadam, DF Quail, ...
Cancer Research 74 (19 Supplement), 4812-4812, 2014
Nanoemulsion formulations for brain tumour therapy
AN Kadam
University of Central Lancashire, 2013
The system can't perform the operation now. Try again later.
Articles 1–7